| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/21/2002 | CA2418365A1 Methods for blocking resistance to bt toxins in insects and nematodes |
| 02/21/2002 | CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | CA2417152A1 Therapeutic compounds for ovarian cancer |
| 02/21/2002 | CA2417141A1 Novel glycoproteins and methods of use thereof |
| 02/21/2002 | CA2415353A1 Use of antibodies against specific mhc-peptide complexes |
| 02/20/2002 | EP1180686A1 Remedies for kidney diseases and method for screening the same |
| 02/20/2002 | EP1180684A1 High estrogen-sensitive medaka fish |
| 02/20/2002 | EP1180525A1 Transcriptional activation inhibitory protein |
| 02/20/2002 | EP1180524A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 02/20/2002 | EP1180168A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS |
| 02/20/2002 | EP1180160A1 Antibiotic-based gene regulation system |
| 02/20/2002 | EP1180159A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 02/20/2002 | EP1180155A1 Vector for integration of heterologous sequences into poxviral genomes |
| 02/20/2002 | EP1180153A1 Phage-dependent super-production of biologically active proteins and peptides |
| 02/20/2002 | EP1180148A1 A VARIANT OF C6 BETA-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY |
| 02/20/2002 | EP1180147A1 Secreted alpha-helical protein-31 |
| 02/20/2002 | EP1180146A1 Secreted alpha-helical protein - 32 |
| 02/20/2002 | EP1180145A1 Biosynthesis of foreign proteins using transformed microalgae |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180142A2 Methods and compositions for measuring ion channel conductance |
| 02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
| 02/20/2002 | EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway |
| 02/20/2002 | EP1180122A1 Structural models for cytoplasmic domains of transmembrane receptors |
| 02/20/2002 | EP1180121A1 Long lasting insulinotropic peptides |
| 02/20/2002 | EP1180120A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 02/20/2002 | EP1180119A2 RECOMBINANT $i(HAEMOPHILUS INFLUENZAE) ADHESIN PROTEINS |
| 02/20/2002 | EP1180118A1 Fimbrial proteins |
| 02/20/2002 | EP1180117A1 Models of prion disease |
| 02/20/2002 | EP1180114A1 Compositions, methods, and kits relating to resistin |
| 02/20/2002 | EP1180041A1 Vaccine against isa virus |
| 02/20/2002 | EP0874992B1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 02/20/2002 | EP0832120B1 Anti-fungal d-amino acid histatin-based peptides |
| 02/20/2002 | EP0804462B1 An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
| 02/20/2002 | EP0792286B1 Peptide analogues at position 91 of human myelin basis protein for treatment of multiple scerosis |
| 02/20/2002 | EP0749485B1 Antimicrobial proteins from impatiens |
| 02/20/2002 | EP0728215B1 METHOD OF BINDING MATERIAL TO THE Beta-AMYLOID PEPTIDE |
| 02/20/2002 | EP0667904B1 Suppressor and progenitor cells |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336935A Compositions and methods for WT1 specific immunotherapy |
| 02/20/2002 | CN1336386A Giant web bombinator polypeptide and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336385A Giant well bombinator proteinase inhibitor and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336384A Giant web bombinator skin peptide and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336383A Giant web bombinin and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336382A Endothelial cell growth resisting engineered protein |
| 02/20/2002 | CN1336381A Trichosanthin mutant and its prepn. |
| 02/20/2002 | CN1336178A Prepn. of blood coagulation factor IX compound |
| 02/20/2002 | CN1079433C Prodn. of fibrinogen in transgenic animals |
| 02/19/2002 | US6348586 Nucleotide sequence of herpes virus; diagnosis; vaccines; viricides; antisense agents; triplex oligonucleotides; |
| 02/19/2002 | US6348585 Amino acid sequence; treatment and diagnosis of cardiovascular, nervous system, and psychological disorders; antiulcer agents; hypotensive/hypertensive agents |
| 02/19/2002 | US6348584 Fibronectin binding protein compounds |
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348578 Apt |
| 02/19/2002 | US6348577 Regulation of aureobasidin sensitivity in fungus |
| 02/19/2002 | US6348576 Human cornichon molecule |
| 02/19/2002 | US6348575 Patched-2 |
| 02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
| 02/19/2002 | US6348573 A protein; diagnosis and therapy for heart disease, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis, liver disorders, heart diseases, and cancer |
| 02/19/2002 | US6348571 Corticotropin release inhibiting factor and methods of using same |
| 02/19/2002 | US6348570 Tetrapeptides; diagnosing and monitoring inflammatory, nervous system, skin, cardiovascular, respiratory system, gastrointestinal, urogenital and immune disorders; evaluating inhibitors |
| 02/19/2002 | US6348569 Spruce budworm antifreeze proteins, genes and method of using same |
| 02/19/2002 | US6348568 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 02/19/2002 | US6348567 A peptide derived from streptokinase; therapy for nervous system disorders, cardiovascular diseases, autoimmune diseases, parkinson's/alzheimer's/huntington's diseases and inflammatory diseases |
| 02/19/2002 | US6348449 Methods of inducing mucosal immunity |
| 02/19/2002 | US6348445 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 02/19/2002 | US6348352 Purging tumor cells from a hematopoietic progenitor cell population by introducing a stable tumor suppressor gene into a heterogeneous cell population and selectively transducing phenotypically hyperproliferative cells |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348350 A nucleic acid that codes a mammalian native ligand tyrosine kinase containing an immunoglobulin and an epidermal growth factor domain; that induces vasculariation; diagnosis and therapy for promoting or inhibiting neovascularization |
| 02/19/2002 | US6348348 A genetically engineered expression vector; diagnosis and therapy for hair loss and dermatologic conditions |
| 02/19/2002 | US6348340 Compounds |
| 02/19/2002 | US6348335 Metabolism active materials, heating and cooling yeasts then isolation |
| 02/19/2002 | US6348334 DNA encoding Fas ligand |
| 02/19/2002 | US6348333 VEGF-binding KDR polypeptide |
| 02/19/2002 | US6348332 DNA molecule encoding gonorrhoeal hybrid PIA/PIB protein |
| 02/19/2002 | US6348331 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter |
| 02/19/2002 | US6348330 Method for measuring human neurokinin-3 receptor ligand binding |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348328 Compounds |
| 02/19/2002 | US6348327 Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
| 02/19/2002 | US6348320 Contacting serum sample with antibody which binds to specified crosslinked peptide, detecting binding of antibody, correlating any detected binding to resorption of unmineralized type ii collagen in vivo |
| 02/19/2002 | US6348317 Fluorescent and DNA cleavage properties of peptide/dye conjugates |
| 02/19/2002 | US6348198 Isolated and purified from a bacterial pathogen selected from neisseria meningitidis, neisseria gonorrhoeae, moraxella catarrhalis, moraxella bovis and moraxella lacunata; immunogenic; |
| 02/19/2002 | US6348196 Feline polynucleotide vaccine formula |
| 02/19/2002 | US6348192 Interleukin-2 mutein expressed from mammalian cells |
| 02/19/2002 | US6348191 Production and use of IL-6 |
| 02/19/2002 | US6348185 Functional moiety linking peptide to diagnostic or pharmaceutically active substance and which confers target cell specificity to said compound; radiotherapy and drug delivery; conjugate coordination and covalent complexes; |
| 02/19/2002 | CA2103889C Process for the phosphorylation of insulin and product produced thereby |
| 02/19/2002 | CA2085953C Human antithrombin-iii preparation |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/18/2002 | CA2317110A1 Plant-gene promotor and methods of using the same |
| 02/14/2002 | WO2002012987A2 Systems and methods for authenticating a user to a web server |
| 02/14/2002 | WO2002012902A2 Split-ubiquitin based reporter systems and methods of their use |
| 02/14/2002 | WO2002012561A2 Haplotypes of the or1g1 gene |
| 02/14/2002 | WO2002012548A1 METHOD OF ANALYZING NFλB ACTIVITY |
| 02/14/2002 | WO2002012540A2 Reaper protein |
| 02/14/2002 | WO2002012539A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | WO2002012538A2 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 02/14/2002 | WO2002012537A2 Mutant trichosanthin |
| 02/14/2002 | WO2002012528A2 Enhanced 2-keto-l-gulonic acid production |
| 02/14/2002 | WO2002012526A2 Materials and methods for delivery and expression of heterologous dna in vertebrate cells |